About Prof. Dr. dr. Achmad Fauzi Kamal, Sp.OT(K) (teaching staff; founding head of the Sp-2 programme)
Appointment status: Portrait identity checked on an official source; current fellowship appointment requires separate confirmation.
Prof. Dr. dr. Achmad Fauzi Kamal, Sp.OT(K) (teaching staff; founding head of the Sp-2 programme) is named in the official programme evidence connected to this page. The source identifies Prof. Dr. dr. Achmad Fauzi Kamal, Sp.OT(K) (teaching staff; founding head of the Sp-2 programme) as Teaching staff (previous FKUI listing) at Faculty of Medicine Universitas Indonesia (FKUI) / RSUPN Dr. Cipto Mangunkusumo (RSCM). The published clinical or academic focus includes Musculoskeletal Oncology.
Within OrthoFellow, Prof. Dr. dr. Achmad Fauzi Kamal, Sp.OT(K) (teaching staff; founding head of the Sp-2 programme) is connected to 1 current programme: Orthopaedic and Traumatology Subspecialist Programme (Sp-2) — Orthopaedic Oncology and Reconstruction track, FKUI / RSCM. These links come from named faculty or programme-lead associations in the cited programme records; they are not inferred from specialty, publication history or geographic proximity.
The associated opportunities span Musculoskeletal Oncology across Indonesia, with clinical fellowship represented. Applicants should open each programme profile separately because faculty involvement does not by itself confirm a current application window, clinical privileges, funding, eligibility or direct supervision for a future intake.
This editorial page summarises source-backed professional and programme relationships already published in OrthoFellow. It does not reproduce an institutional biography or claim endorsement by Prof. Dr. dr. Achmad Fauzi Kamal, Sp.OT(K) (teaching staff; founding head of the Sp-2 programme). The official individual profile remains the primary source for current appointments and credentials, while each linked programme profile records its own evidence, status and verification date.
Appointments and faculty rosters can change. The official individual profile and programme source remain authoritative.